Bibliography
- Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1-alpha in common human cancers and their metastases. Cancer Res 1999;59(22):5830-5
- Zhong H, Qian DZ, Tan YS, et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci USA 2008;105:19579-86
- Stenkvist B. Is digitalis a therapy for breast carcinoma? Oncol Rep 1999;6(3):493-6
- Haux J. Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 1999;53(6):543-8
- McConkey DJ, McConkey DJ, Lin Y, Nutt LK, et al. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 2000;60(14):3807-12
- Bielawski K, Winnicka K, Bielawska A. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull 2006;29(7):1493-7
- Mekhail T, Mekhail T, Kaur H, Ganapathi R, et al. Phase 1 trial of Anvirzel in patients with refractory solid tumors. Invest New Drugs 2006;24(5):423-7
- Giatromanolaki A, Koukourakis MI, Simopoulos C, et al. c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1-alpha dependent. Clin Cancer Res 2004;10(23):7972-7
- Lim JH, Lee ES, You HJ, et al. Ras-dependent induction of HIF-1-alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 2004;23(58):9427-31
- Shintani K, Matsumine A, Kusuzaki K, et al. Expression of hypoxia-inducible factor (HIF)-1-alpha as a biomarker of outcome in soft-tissue sarcomas. Virchows Arch 2006;449(6):673-81
- Katzung BG, Parmley WW. Cardiac glycosides and other drugs used in congestive heart failure. 8 edition. In: Katzung BG, editor, Basic and clinical pharmacology. New York: McGraw-Hill; 2001. p. 200-18